Evidence map›Paper›PMID 33517478›Full record

ArticleAnalytical and bioanalytical chemistry2021

Mass shift in mass spectrometry imaging: comprehensive analysis and practical corrective workflow.

Andréa McCann, Sophie Rappe, Raphaël La Rocca, Mathieu Tiquet, Loïc Quinton, Gauthier Eppe, Johann Far, Edwin De Pauw, Christopher Kune

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. A Novel Peak-Shape Aware Approach for Mass Alignment in Mass Spectrometry.Rapid communications in mass spectrometry : RCM · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Organ-resolved lipid mapping inFrontiers in chemistry · 2025
    Article
  8. Article
  9. Article
  10. Normalization Based onMass spectrometry (Tokyo, Japan) · 2024
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andréa McCann *Mass Spectrometry Laboratory, MolSys Research Unit, Department of Chemistry, University of Liège, Allée du Six Août, 11 - Quartier Agora, 4000, Liège, Belgium.
Sophie Rappe *Mass Spectrometry Laboratory, MolSys Research Unit, Department of Chemistry, University of Liège, Allée du Six Août, 11 - Quartier Agora, 4000, Liège, Belgium.
Raphaël La RoccaMass Spectrometry Laboratory, MolSys Research Unit, Department of Chemistry, University of Liège, Allée du Six Août, 11 - Quartier Agora, 4000, Liège, Belgium.
Mathieu TiquetMass Spectrometry Laboratory, MolSys Research Unit, Department of Chemistry, University of Liège, Allée du Six Août, 11 - Quartier Agora, 4000, Liège, Belgium.
Loïc QuintonMass Spectrometry Laboratory, MolSys Research Unit, Department of Chemistry, University of Liège, Allée du Six Août, 11 - Quartier Agora, 4000, Liège, Belgium.
Gauthier EppeMass Spectrometry Laboratory, MolSys Research Unit, Department of Chemistry, University of Liège, Allée du Six Août, 11 - Quartier Agora, 4000, Liège, Belgium.
Johann FarMass Spectrometry Laboratory, MolSys Research Unit, Department of Chemistry, University of Liège, Allée du Six Août, 11 - Quartier Agora, 4000, Liège, Belgium.
Edwin De PauwMass Spectrometry Laboratory, MolSys Research Unit, Department of Chemistry, University of Liège, Allée du Six Août, 11 - Quartier Agora, 4000, Liège, Belgium.
Christopher KuneMass Spectrometry Laboratory, MolSys Research Unit, Department of Chemistry, University of Liège, Allée du Six Août, 11 - Quartier Agora, 4000, Liège, Belgium. c.kune@uliege.be.ORCID http://orcid.org/0000-0002-3010-8173

Funding

European Union's Horizon 2020 research and innovation program 731077Excellence Of Science Program of the FNRS F.R.S (Rhizoclip) EOS30650350FEDER BIOMED HUB Technology 2.2.1/996Interreg's EURLIPIDS project R-8598
6 · The paper itself

Abstract

MALDI mass spectrometry imaging (MSI) allows the mapping and the tentative identification of compounds based on their m/z value. In typical MSI, a spectrum is taken at incremental 2D coordinates (pixels) across a sample surface. Single pixel mass spectra show the resolving power of the mass analyzer. Mass shift, i.e., variations of the m/z of the same ion(s), may occur from one pixel to another. The superposition of shifted masses from individual pixels peaks apparently degrades the resolution and the mass accuracy in the average spectrum. This leads to low confidence annotations and biased localization in the image. Besides the intrinsic performances of the analyzer, the sample properties (local composition, thickness, matrix deposition) and the calibration method are sources of mass shift. Here, we report a critical analysis and recommendations to mitigate these sources of mass shift. Mass shift 2D distributions were mapped to illustrate its effect and explore systematically its origin. Adapting the sample preparation, carefully selecting the data acquisition settings, and wisely applying post-processing methods (i.e., m/z realignment or individual m/z recalibration pixel by pixel) are key factors to lower the mass shift and to improve image quality and annotations. A recommended workflow, resulting from a comprehensive analysis, was successfully applied to several complex samples acquired on both MALDI ToF and MALDI FT-ICR instruments.

Indexed as

Data recalibrationFT-ICRMass accuracyMass shiftMass spectrometry imagingTime of flight

Identifiers

PMID33517478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.